Haem oxygenase-1 - A culprit in vascular and renal damage?

Nephrology Dialysis Transplantation

Volumn 22, Issue 6, 2007, Pages 1495-1499

  Hill Kapturczak, Nathalie ^a   Agarwal, Anupam ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

Acute renal injury; Atherosclerosis; Haem oxygenase; Vascular neointimal proliferation

Indexed keywords

ADENOVIRUS VECTOR; BILIVERDIN; CARBON MONOXIDE; HEME ARGINATE; HEME DERIVATIVE; HEME OXYGENASE 1; HEME OXYGENASE INHIBITOR; HEMIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LYSINE; METALLOPORPHYRIN; PACLITAXEL; PROBUCOL; RAPAMYCIN; RETROVIRUS VECTOR; TIN CHLORIDE;

ACUTE DISEASE; APOPTOSIS; ATHEROSCLEROSIS; BLOOD VESSEL INJURY; BYSTANDER EFFECT; CELL PROTECTION; CHRONIC KIDNEY DISEASE; CYTOTOXICITY; DISEASE COURSE; DISEASE EXACERBATION; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME DEFICIENCY; ENZYME DEGRADATION; ENZYME INHIBITION; ENZYME LOCALIZATION; ENZYME MECHANISM; GENE EXPRESSION REGULATION; GENETIC CODE; HEMODIALYSIS; HUMAN; HYPERTENSION; KIDNEY FAILURE; KIDNEY INJURY; NONHUMAN; NONVIRAL GENE THERAPY; NOTE; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RENAL PROTECTION; SICKLE CELL ANEMIA; TREATMENT FAILURE; UPREGULATION; VASCULAR ENDOTHELIUM; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; HEME OXYGENASE-1; HUMANS; KIDNEY DISEASES; VASCULAR DISEASES;

EID: 34447579299     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm093     Document Type: Note

References (58)

1. Maines MD. The heme oxygenase system: A regulator of second messenger gases. Annu Rev Pharmacol Toxicol 1997; 37: 517-554
2. Hill-Kapturczak N, Chang SH, Agarwal A. Heme oxygenase and the kidney. DNA Cell Biol 2002; 21: 307-321
3. Nath KA. Heme oxygenase-1: A provenance for cytoprotective pathways in the kidney and other tissues. Kidney Int 2006; 70: 432-443
4. Abraham NG, Kappas A. Heme oxygenase and the cardiovascular-renal system. Free Radic Biol Med 2005; 39: 1-25
5. Morita T. Heme oxygenase and atherosclerosis. Arterioscler Thromb Vasc Biol 2005; 25: 1786-1795
6. Maruhashi K, Kasahara Y, Ohta K et al. Paradoxical enhancement of oxidative cell injury by overexpression of heme oxygenase-1 in an anchorage-dependent cell ECV304. J Cell Biochem 2004; 93: 552
7. Suttner DM, Dennery PA. Reversal of HO-1 related cytoprotection with increased expression is due to reactive iron. FASEB J 1999; 13: 1800-1809
8. Kapitulnik J. Bilirubin: An endogenous product of heme degradation with both cytotoxic and cytoprotective properties. Mol Pharmacol 2004; 66: 773-779
9. Zhang J, Piantadosi CA. Mitochondrial oxidative stress after carbon monoxide hypoxia in the rat brain. J Clin Invest 1992; 90: 1193-1199
10. Schipper HM. Brain iron deposition and the free radical-mitochondrial theory of ageing. Ageing Res Rev 2004; 3: 265-301
11. Inguaggiato P, Gonzalez-Michaca L, Croatt AJ, Haggard JJ, Alam J, Nath KA. Cellular overexpression of heme oxygenase-1 up-regulates p21 and confers resistance to apoptosis. Kidney Int 2001; 60: 2181-2191
12. Li Volti G, Wang J, Traganos F, Kappas A, Abraham NG. Differential effect of heme oxygenase-1 in endothelial and smooth muscle cell cycle progression. Biochem Biophys Res Commun 2002; 296: 1077-1082
13. Deramaudt BM, Braunstein S, Remy P, Abraham NG. Gene transfer of human heme oxygenase into coronary endothelial cells potentially promotes angiogenesis. J Cell Biochem 1998; 68: 121-127
14. Liu XM, Chapman GB, Wang H, Durante W. Adenovirus-mediated heme oxygenase-1 gene expression stimulates apoptosis in vascular smooth muscle cells. Circulation 2002; 105: 79-84
15. Bussolati B, Mason JC. Dual role of VEGF-induced heme-oxygenase-1 in angiogenesis. Antioxid Redox Signal 2006; 8: 1153-1163
16. Sunamura M, Duda DG, Ghattas MH et al. Heme oxygenase-1 accelerates tumor angiogenesis of human pancreatic cancer. Angiiogenesis 2003; 6: 15-24
17. Nowis D, Legat M, Grzela T et al. Heme oxygenase-1 protects tumor cells against photodynamic therapy-mediated cytotoxicity. Oncogene 2006; 25: 3365-3374
18. Berberat PO, Dambrauskas Z, Gulbinas A et al. Inhibition of heme oxygenase-1 increases responsiveness of pancreatic cancer cells to anticancer treatment. Clin Cancer Res 2005; 11: 3790-3798
19. Agarwal A, Nick HS. Renal response to tissue injury: Lessons from heme oxygenase-1 gene ablation and expression. J Am Soc Nephrol 2000; 11: 965-973
20. Togane Y, Morita T, Suematsu M, Ishimura Y, Yamazaki JI, Katayama S. Protective roles of endogenous carbon monoxide in neointimal development elicited by arterial injury. Am J Physiol Heart Circ Physiol 2000; 278: H623-632
21. Tulis DA, Durante W, Liu X, Evans AJ, Peyton KJ, Schafer AI. Adenovirus-mediated heme oxygenase-1 gene delivery inhibits injury-induced vascular neointima formation. Circulation 2001; 104: 2710-2715
22. Tulis DA, Durante W, Peyton KJ, Evans AJ, Schafer AI. Heme oxygenase-1 attenuates vascular remodeling following balloon injury in rat carotid arteries. Atherosclerosis 2001; 155: 113-122
23. Otterbein LE, Zuckerbraun BS, Haga M et al. Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury. Nat Med 2003; 9: 183-190
24. Ollinger R, Bilban M, Erat A et al. Bilirubin: A Natural Inhibitor of Vascular Smooth Muscle Cell Proliferation. Circulation 2005; 112: 1030-1039
25. Nakao A, Murase N, Ho C, Toyokawa H, Billiar TR, Kanno S. Biliverdin Administration Prevents the Formation of Intimal Hyperplasia Induced by Vascular Injury. Circulation 2005; 112: 587-591
26. Choi BM, Kim YM, Jeong YR et al. Induction of heme oxygenase-1 is involved in anti-proliferative effects of paclitaxel on rat vascular smooth muscle cells. Biochem Biophys Res Commun 2004; 321: 132-137
27. Visner GA, Lu F, Zhou H, Liu J, Kazemfar K, Agarwal A. Rapamycin induces heme oxygenase-1 in human pulmonary vascular cells: Implications in the antiproliferative response to rapamycin. Circulation 2003; 107: 911-916
28. Zhou H, Liu H, Porvasnik SL et al. Heme oxygenase-1 mediates the protective effects of rapamycin in monocrotaline-induced pulmonary hypertension. Lab Invest 2006; 86: 62-71
29. Exner M, Minar E, Wagner O, Schillinger M. The role of heme oxygenase-1 promoter polymorphisms in human disease. Free Radic Biol Med 2004; 37: 1097-1104
30. Lin CC, Yang WC, Lin SJ et al. Length polymorphism in heme oxygenase-1 is associated with arteriovenous fistula patency in hemodialysis patients. Kidney Int 2006; 69: 165-172
31. Ishikawa K, Sugawara. D, Wang X-P et al. Heme Oxygenase-1 inhibits atherosclerotic lesion formation in LDL-receptor knockout mice. Circ Res 2001; 88: 506-512
32. Ishikawa K, Sugawara D, Goto J et al. Heme Oxygenase-1 inhibits atherogenesis in Watanabe heritable hyperlipidemic rabbits. Circulation 2001; 104: 1831-1836
33. Juan S-H, Lee T-S, Tseng K-W et al. Adenovirus-Mediated Heme Oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein E-deficient mice. Circulation 2001; 104: 1519-1525
34. Yet SF, Layne MD, Liu X et al. Absence of heme oxygenase-1 exacerbates atherosclerotic lesion formation and vascular remodeling. Faseb J 2003; 17: 1759-1761
35. Chen S, Segal M, Agarwal A. "Lumen digestion" technique for isolation of aortic endothelial cells from heme oxygenase-1 knockout mice. Biotechniques 2004; 37: 84-89
36. Yano Y, Ozono R, Oishi Y et al. Genetic ablation of the transcription repressor Bach1 leads to myocardial protection against ischemia/reperfusion in mice. Genes Cells 2006; 11: 791-803
37. Omura S, Suzuki H, Toyofuku M, Ozono R, Kohno N, Igarashi K. Effects of genetic ablation of bach1 upon smooth muscle cell proliferation and atherosclerosis after caff injury. Genes to Cells 2005; 10: 277-285
38. Jeney V, Balla J, Yachie A et al. Pro-oxidant and cytotoxic effects of circulating heme. Blood 2002; 100: 879-887
39. Kawashima A, Oda Y, Yachie A, Koizumi S, Nakanishi I. Heme oxygenase-1 deficiency: The first autopsy case. Hum Pathol 2002; 33: 125-130
40. Hancock WW, Buelow R, Sayegh MH, Turka LA. Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes. Nat Med 1998; 4: 1392-1396
41. Lee TS, Chang CC, Zhu Y, Shyy JY. Simvastatin induces heme oxygenase-1: a novel mechanism of vessel protection. Circulation 2004; 110: 1296-1302
42. Wu BJ, Kathir K, Witting PK et al. Antioxidants protect from atherosclerosis by a heme oxygenase-1 pathway that is independent of free radical scavenging. J Exp Med 2006; 203: 1117-1127
43. Wang R, Shamloul R, Wang X, Meng Q, Wu L. Sustained normalization of high blood pressure in spontaneously hypertensive rats by implanted hemin pump. Hypertension 2006; 48: 685-692
44. Motterlini R, Gonzales A, Foresti R, Clark JE, Green CJ, Winslow RM. Heme Oxygenase-1-derived carbon monoxide contributes to the suppression of acute hypertensive responses in vivo. Circ Res 1998; 83: 568-577
45. Wang R, Wu L. The chemical modification of KCa channels by carbon monoxide in vascular smooth muscle cells. J Biol Chem 1997; 272: 8222-8226
46. Morita T, Perrella MA, Lee ME, Kourembanas S. Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP. Proc Natl Acad Sci U S A 1995; 92: 1475-1479
47. Johnson FK, Johnson RA, Durante W, Jackson KE, Stevenson BK, Peyton KJ. Metabolic syndrome increases endogenous carbon monoxide production to promote hypertension and endothelial dysfunction in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol 2006; 290: R601-608
48. Teran FJ, Johnson RA, Stevenson BK et al. Heme oxygenase-derived carbon monoxide promotes arteriolar endothelial dysfunction and contributes to salt-induced hypertension in Dahl salt-sensitive rats. Am J Physiol Regul Integr Comp Physiol 2005; 288: R615-622
49. Kaide J-I, Zhang F, Wei Y et al. Carbon monoxide of vascular origin attenuates the sensitivity of renal arterial vessels to vasoconstrictors. J Clin Invest 2001; 107: 1163-1171
50. Thorup C, Jones CL, Gross SS, Moore LC, Goligorsky MS. Carbon monoxide induces vasodilation and nitric oxide release but suppresses endothelial NOS. Am J Physiol Renal Physiol 1999; 277: F882-889
51. Nath KA, Balla G, Vercellotti GM et al. Induction of heme oxygenase is a rapid, protective response in rhabdomyolysis in the rat. J Clin Invest 1992; 90: 267-270
52. Nath KA, Haggard JJ, Croatt AJ, Grande JP, Poss KD, Alam J. The indispensability of heme oxygenase-1 in protecting against acute heme protein-induced toxicity in vivo. Am J Pathol 2000; 156: 1527-1535
53. Pittock ST, Norby SM, Grande JP et al. MCP-1 is up-regulated in unstressed and stressed HO-1 knockout mice: Pathophysiologic correlates. Kidney Int 2005; 68: 611-622
54. Shiraishi F, Curtis LM, Truong L et al. Heme oxygenase-1 gene ablation or expression modulates cisplatin-induced renal tubular apoptosis. Am J Physiol Renal Physiol 2000; 278: F726-736
55. Nath KA, Grande JP, Haggard JJ et al. Oxidative Stress and Induction of Heme Oxygenase-1 in the Kidney in Sickle Cell Disease. Am J Pathol 2001; 158: 893-903
56. Belcher JD, Mahaseth H, Welch TE, Otterbein LE, Hebbel RP, Vercellotti GM. Heme oxygenase-1 is a modulator of inflammation and vaso-occlusion in transgenic sickle mice. J Clin Invest 2006; 116: 808-816
57. Juncos JP, Grande JP, Murali N et al. Anomalous renal effects of tin protoporphyrin in a murine model of sickle cell disease. Am J Pathol 2006; 169: 21-31
58. Nath KA, Agarwal A, Vogt BA. Functional consequences of induction of heme oxygenase. In: Goligorsky MS, Stein JH, eds. Contemporary Issues in Nephrology: Special issue: Acute renal failure: New concepts and therapeutic strategies. Churchill-Livingstone, New York, USA: 1995; 97-118